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Summary
Platelet rich plasma has been used in the treatment
of tendinopathies, but the sonographic modifica-
tions of tendons have received less attention. In
this paper we report the results of an ultrasound
evaluation, performed during and after plasma in-
jection, in patients with tendinopathy.
The sonographic abnormalities and neovasculariza-
tion were registered in twenty tendons. Three plas-
ma injections (once a week) were performed, and a
rehabilitation program was recommended. Pain and
patients’ satisfaction were evaluated. 
During the injections plasma spread along the col-
lagen fibers, and an intratendineous cleft produced
by the injected volume was observed. At 12 months
two tendons regained a normal echotexture, while
neovessels were absent in seven. The remaining
tendons showed less abnormalities and neovascu-
larization in comparison with baseline. The clinical
improvement was earlier and more consistent. 
The discrepancy between the ultrasound and clini-
cal results may be explained by the peculiar modal-
ities of tendon healing induced by plasma adminis-
tration.
KEY WORDS: neovascularization, platelet rich plasma,
tendinopathy, ultrasound. 
Introduction
The efficacy of Platelet Rich Plasma (PRP) in the treat-
ment of tendinopathies has been proven by several clin-
ical studies1-15. However, the sonographic modifications
of treated tendons have received less attention, and on-
ly in few studies have been specifically addressed, us-
ing semiquantitative measures2, 16, 17. Available observa-
tions put in evidence that there is only little structural im-
provement in the long term follow-up, but data about the
changes in neovascularization are conflicting. Moreover,
only one study has been published about the in vivo
spreading of PRP during the injection18.
Given the paucity of these informations, in this paper
we report a case series of subjects with tendinopathy
treated with PRP, where a systematic and semiquanti-
tative sonographic evaluation was performed during the
injection and at regular intervals in one year follow-up. 
Materials and methods
This is an open design observational study with a 12
months follow-up period, following basic principles
and recommendations in clinical and field science re-
search19.
Patients referred to the Echography Unit of our De-
partment for PRP treatment of tendinopathies were
enrolled. At baseline, demographic and anthropomet-
ric data (sex, age, BMI) were collected. Pain during
the previous week, both at rest and during activities,
was registered by means of a 0-10 cm visual ana-
logue scale (VAS). 
Before PRP injection, participants underwent an ultra-
sound (US) and Power Doppler (PD) evaluation of
the affected tendon, using a high-resolution, multi-fre-
quency (6-15 MHz) linear array transducer (ProSound
ALPHA10, Aloka, Japan). Both longitudinal and trans-
verse scans were taken. 
The US criteria adopted for the diagnosis of
tendinopathies were the following. The presence of
dishomogeneous hypo- or hyperechoic thickening,
diffuse or focal, of the tendon, associated with loss of
the normal fibrillar pattern and/or irregularity of the
tendon margins, was interpreted as sign of degenera-
tion. On the basis of these structural abnormalities,
tendons were stratified for severity as “mild” (one
area of disorganized echotexture), “moderate” (some
areas of disorganized echotexture), and “severe” (dis-
organized echotexture and diffuse hypo- or hypere-
choic areas and/or calcifications)20.
Presence of neovascularization was estimated by
means of PD and graded as (0), (1+), (2++), (3+++),
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(4++++), according to the appearance of vessels in-
side the tendon21. To avoid artifacts, sensitivity was
optimized for low flow, and the gain was set just be-
low the noise level. 
After the diagnostic evaluation, in sterile conditions
and under US-guidance, small autologous pure PRP
depots were left at several sites into the degenerate
tendon areas using a 21G needle; PRP was placed at
the site of most damaged areas, and then proximal
and distal, for a total amount of 4 ml. No regional
anesthetic was used. During the injection, the PRP
US distribution pattern into the tendon, and the ves-
sels appearance, before and after the procedure, was
evaluated. 
A total of 3 injections (once a week) was performed.
After the second injection, a rehabilitation program,
based on eccentric training and stretching, was rec-
ommended daily (3 sets x 15 repetitions) at least for
3 months, during which a gradual return to sport ac-
tivities was encouraged.
The US and clinical assessment was repeated at 3, 6
and 12 months after the last injection, evaluating: a)
changes in tendon structures and vascularization; b)
pain, both at rest and during activities; c) patients sat-
isfaction (in terms of pain and function) by means of
five-points Likert Scale (Not satisfied; Slightly satis-
fied; Somewhat satisfied; Very satisfied; Extremely
satisfied)22.
The US scans and the injection procedures were per-
formed by the same well-trained operator (AM).
The study was performed according to the Declara-
tion of Helsinki, and informed written consent was ob-
tained from all the patients.
Statistical analysis
Data are reported as mean ± SD for continuous vari-
ables, whereas categorical and dichotomous vari-
ables are reported as frequencies and percentage.
The significance level was determined at p <0.05.
The two-sample Student’s t-test was used to com-
pare continuous variables, when the distribution of
data was normal; the Wilcoxon’s rank sum test was
used otherwise. The χ2 test was used to evaluate as-
sociations between categorical data.
Results
Twenty patients were evaluated (17 males and 3 fe-
males; mean age 41.2 ± 15 years; range 18-68 years;
BMI 24.7 ± 3.3).
At baseline all tendons (11 Achilles, 5 elbow, and 4
patellar tendons) showed sonographic structural ab-
normalities: mild alterations were observed in 4 cas-
es, while moderate and severe damage was found in
12 and 4 tendons, respectively (Tab. 1). Intratendi-
nous neovascularization was present in 17/20 ten-
dons, and graded as (1+), (2++), (3+++), (4++++) in
1, 8, 5, and 3 cases, respectively (Tab. 2).
During the injections a constant feature was the ob-
servation of PRP spreading (as hypo/hyperechoic
material) along the collagen fibers, also at some cen-
timeters from the tip of the needle, associated to a si-
multaneous bulging of the whole tendon. An intra-
tendineous cleft was produced by the injected volume
and appeared as an anechoic area with irregular mar-
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Table 1. Sonographic features of the tendons treated.
Baseline 3 months 6 months 12 months p *
Normal 0 2 (10%) 2 (10%) 2 (10%)
US abnormalities 20 18 (90%) 18 (90%) 18 (90%) ns
• Mild 4 (20%) 2 (11.1%) 4 (11.1%) 8 (44.4%) ns
• Moderate 12 (60%) 12 (66.6%) 12 (66.6%) 9 (50%) ns
• Severe 4 (20%) 4 (22.2%) 2 (22.2%) 1 (5.5%) ns
* Baseline versus 12 months 
Summing up moderate and severe lesions, the comparison between baseline and 12 months follow-up values shows a sig-
nificant difference (16/20 vs 10/18; p=0.04) 
Table 2. Neovascularization.
Baseline 3 months 6 months 12 months p *
Absent 3 (15%) 3 (15%) 4 (20%) 7 (35%) ns
Present 17 (85%) 17 (85%) 16 (80%) 13 (65%) ns
(+1) 1 (5.8%) 4 (23.5%) 5 (31.2%) 8 (61.5%) 0.001
(+2) 8 (47%) 5 (29.4%) 8 (50%) 4 (30.7%) ns
(+3) 5 (29.4%) 6 (35.2%) 3 (18.7%) 1 (7.6%) ns
(+4) 3 (17.6%) 2 (11.7%) 0 0 ns
* Baseline versus 12 months 
Summing up higher degrees [(+3) and (+4)], the comparison between baseline and 12 months follow-up values shows a sig-
nificant difference (8/17 vs 1/13; p=  0.01) 
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gins. At the end of the procedure neovessels com-
pletely disappeared in the region of interest of all the
tendons treated (Fig. 1).
At 3, 6, and 12 months after treatment only two ten-
dons (2 elbow extensors) regained a normal echotex-
ture (Fig. 2), while the remaining, albeit less abnor-
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Sonography and PRP injection
Figure 1. Sonographic find-
ings during, after, and at
the end of an ultrasound
guided injection for the
treatment of Achilles mid-
portion tendinopathy. 
Before the procedure,
Achilles tendon appears
thickened (calipers) and hy-
poechoic areas are ob-
served at the midportion
level (panel 1). Neovessels
can be detected in the ven-
tral and distal portion of the
tendon (arrow) (panel 3).
During the procedure, the
injected volume unsticks
the collagen fibers, also at
some centimeters from the
tip of the needle, and an in-
terstitial cleft (anechoic
area) is seen (dot lines); a
simultaneous bulging of the
whole tendon is observed
(calipers) (panel 2). At the
end of the injection neoves-
sels completely disappear
(panel 4).
C= Calcaneal bone; *=
retrocalcaneal bursitis
Figure 2. Sonographic im-
provement in a patient with
elbow extensors tendinopa-
thy. 
At baseline, the extensor
tendons appear thickened
(calipers) and hypoechoic
(*) (moderate damage)
(panel 1); neovasculariza-
tion is clearly seen at the
insertional level with power
doppler (3+++) (arrow)
(panel 2). 
At 12 months follow-up,
tendon thickness is re-
duced and tendon echotex-
ture appears more normal,
although some hypoechoic
areas are seen at the inser-
tional level (*) (panel 3);
neovessels are reduced
(arrow) (panel 4).
E= Medial Epicondyle; C=
Radial Capitellum
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malities were observed, yet showed US damage.
Three Achilles and two patellar tendons did not show
any changes. Summing up the cases with severe and
moderate US abnormalities, at 12 months, a signifi-
cant decrease was found; conversely, those with mild
and absent US abnormalities increased (Tab. 1).
Likewise, the presence and degree of neovessels de-
creased during the whole length of the study, and
neovascularization was absent in seven tendons at
the final follow-up (Fig. 2). The patients with (1+) neo-
vascularization increased significantly, and converse-
ly those with the highest degrees [(3+++) and
(4++++)] decreased (p= 0.01) (Tab. 2).
Pain, both at rest and during activities, significantly
decreased at 3, 6, and 12 months (Graph 1). At the
end of the treatment, 5 patients (25%) were extreme-
ly satisfied, while 6 (30%) were very satisfied; the
comparison between 3 and 12 months follow-up was
statistically significant (Tab. 3).
Discussion
The present study shows that, after PRP injections,
tendon echotexture improves slightly over time. In-
deed, after 12 months, 2/20 tendons resumed a nor-
mal US pattern, while the remaining revealed a reduc-
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tion in the US severity score, which reached statistical
significance when the cases with moderate and se-
vere abnormalities were considered as a whole. In ad-
dition, the degree of intratendineous vascularization
significantly decreased. These observations are in
agreement with other studies where an assessment of
US and PD patterns after PRP injections was per-
formed4, 6, 17. Indeed, a reduction in the number of hy-
poechoic areas and in the tendon thickness in the mid
and long term (6-12 months), with a more regular ten-
don appearance, was observed4, 6, 17.
It is, however, noteworthy that symptoms (function
and pain, both at rest and during activities) improved
earlier and more consistently in comparison with the
US echo-structure, and that significant improvement
was observed also in subjects with persistent sono-
graphic abnormalities. Our hypothesis is that US ab-
normalities can persist in tendons perfectly healed,
even if with scar tissue inside. On the other side, the
US method provides only a rough estimation of the
subtle morphologic features of the tendon. 
Despite no simple rule can be generalized to describe
how PRP works for the treatment of tendinopathy, the
positive clinical outcomes can be related to the ability
of platelets to regulate various healing mechanisms,
that is influencing the inflammatory response, modu-
lating angiogenesis, and inducing cell migration and
Graph 1. VAS scores, at rest and during activities, in the follow-up periods.
Table 3. Patients’ satisfaction during the study periods.
3 months 6 months 12 months
Not satisfied 4 (20%) 3 (15%) 2 (10%)
Slightly satisfied 7 (35%) 5 (25%) 3 (15%)
Somewhat satisfied 6 (30%) 4 (20%) 4 (20%)
Very satisfied 3 (15%) 5 (25%) 6 (30%)
Extremely satisfied 0 3 (15%) 5 (25%)
Summing up the patients very and extremely satisfied, the comparison between 3 months and 12 months is statistically sig-
nificant (3/20 vs 11/20 pts; p= 0.008).
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proliferation23, 24. In the short-term, the factors re-
leased by the platelets lower inflammation and modu-
late the pain receptors sensibility, so explaining the
positive clinic results; after wards the cell proliferation
takes place, with collagen and matrix deposition, and
tissue remodeling. Cells usually originate from multi-
potent stem cells in adjacent tissues, while epitenon
tenoblasts, and internal tenocytes contribute to the in-
trinsic repair process. The final outcome is scar tis-
sue formation, which can partially restore tendon
function.
However, discrepancies in the healing processes be-
tween tendons are observed. These can be related to
the specific functions of tendons themselves. Indeed,
weight-bearing tendons, such patellar and Achilles,
can be exposed to higher loads (overload), and there-
fore to an increased strain in comparison to non-load
bearing, such elbow extensors, tendons22.
These features can explains the apparent discrepan-
cy between the imaging findings and the clinical
symptomatology25 .
As far as the analysis of neovascularisation is consid-
ered, the present study shows an evident decrease in
the follow-up. This finding is in agreement with other
studies6, 17, but in contrast with the observations of
Ferrero4 and De Vos16, who observed a significant in-
crease after treatment. It is very difficult to explain
these discrepancies, which can be related to the re-
lease from the platelets both of Vascular Endothelial
Growth Factor and of antiangiogenetic factors, which
are in turn expressed according to intrinsic and ex-
trinsic influences. In our cases, we hypothise that, be-
side the complex biochemical machinery, a role could
be ascribed to the mechanical effects of the eccentric
training, which was performed regularly by the pa-
tients. Indeed, it is has been shown in Achilles
tendinopathy that the flow in neovessels stops when
the ankle joint is in dorsiflexion, whilst in the resting
position there is flow again20, 26. A further explanation
could be the neovessels damage due to the mechani-
cal action of injected volume.
Finally, we remark another finding, i.e. the US and
PD changes into the tendon during PRP injections.
Indeed, in all tendons, PRP preparation spread along
the interfibrillary spaces, also at some centimeters
from the tip of the needle, with a simultaneous
bulging of the whole tendon. These observations are
in agreement with two other studies on PRP diffusion,
the first on cadavers27, the second in vivo under US
control18. We think that PRP diffusion can be as-
cribed to the unsticking of the interfibrillary septa,
where the collagen, in chronic tendinopathies, is
loose and weak, and therefore more prone to tear.
The observation of an anechoic intratendineous cleft
during the procedure further support this statement. 
The distribution beyond the site of deposition, over a
wider region, may eliminate the need for more ex-
tensive injections (the so called “peppering tech-
nique”)5, 6. On the other hand, the tracking of the in-
jectate along the tendon allows the sonographer to
adjuste the needle position, when he deems that
there is excessive dispersion away from the target-
ed site, a condition that may cause the treatment
failure. Noteworthy, at the end of the procedure, the
neovessels completely disappeared in the region of
interest of all the tendons treated, probably because
of the temporary mechanical compression by the
PRP injected nearby. 
Some limitations of the present study must be ac-
knowledged. First, a small number of subjects was
evaluated, making difficult any consideration about
the differences observed between different tendons;
second, a control group submitted simply to dry
needling was lacking. Indeed, the needling procedure
has been proven efficacious by several authors12, 28,
and no difference in echo-structure has been ob-
served after treatment with this technique and PRP
injections16. Third, a comparison between different
PRP compound, i.e. pure PRP versus leukocytes rich
plasma, cannot be made. In the present study we
used pure PRP because we believe that the presence
of leukocytes in the preparation may have a deleteri-
ous effect by synthesizing prostaglandins, reactive
oxygen intermediates, elastases and other proteases,
thus reducing the activity of growth factors and cy-
tokines, with detrimental effects in the quality of the
repaired tissue22.
In conclusion, our US study during and after PRP in-
jection shows a slight but evident improvement of ten-
don abnormalities, which, however, are less evident
in comparison with the more consistently positive
clinical results. In the future, the US modifications
should be studied on larger numbers of tendons sub-
categories (e.g. broad flat versus narrow circular/
ovoid tendons; tendons with a synovial sheath versus
tendons within a paratenon) and using PRP prepara-
tions with different composition to evaluate possible
sonographic differences after treatment.
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